These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Validation of the French version of the situational characteristics questionnaire in the measurement of space and motion discomfort]. Vaillancourt L; Bélanger C; Léger-Bélanger MP; Jacob RG Encephale; 2012 Jun; 38(3):248-56. PubMed ID: 22726413 [TBL] [Abstract][Full Text] [Related]
5. Agoraphobia in men. Hafner RJ Aust N Z J Psychiatry; 1981 Sep; 15(3):243-9. PubMed ID: 6949583 [TBL] [Abstract][Full Text] [Related]
6. Change in danger cognitions in agoraphobia and social phobia during treatment. Poulton RG; Andrews G Behav Res Ther; 1996; 34(5-6):413-21. PubMed ID: 8687363 [TBL] [Abstract][Full Text] [Related]
7. The fear questionnaire. Some data on validity, reliability and layout. Van Zuuren FJ Br J Psychiatry; 1988 Nov; 153():659-62. PubMed ID: 3255455 [TBL] [Abstract][Full Text] [Related]
8. Hypochondriacal fears and beliefs in agoraphobia. Fava GA; Kellner R; Zielezny M; Grandi S J Affect Disord; 1988; 14(3):239-44. PubMed ID: 2898492 [TBL] [Abstract][Full Text] [Related]
9. Predicting the outcome of behaviour therapy for agoraphobia. Hafner RJ; Ross MW Behav Res Ther; 1983; 21(4):375-82. PubMed ID: 6138026 [No Abstract] [Full Text] [Related]
10. Factors in the panic-agoraphobia transition. Katerndahl DA J Am Board Fam Pract; 1989; 2(1):10-6. PubMed ID: 2635873 [TBL] [Abstract][Full Text] [Related]
11. The social validity of treatments for agoraphobia. Norton GR; Allen GE; Hilton J Behav Res Ther; 1983; 21(4):393-9. PubMed ID: 6626109 [No Abstract] [Full Text] [Related]
12. Agoraphobia with and without current panic attacks. Brown R; Munjack D; McDowell D Psychol Rep; 1989 Apr; 64(2):503-6. PubMed ID: 2710892 [TBL] [Abstract][Full Text] [Related]
13. Personality and treatment response in agoraphobia with panic attacks. Clair AL; Oei TP; Evans L Compr Psychiatry; 1992; 33(5):310-8. PubMed ID: 1395550 [TBL] [Abstract][Full Text] [Related]
14. Different rates of improvement of different symptoms in combined pharmacological and behavioral treatment of agoraphobia. Cox DJ; Ballenger JC; Laraia M; Hobbs WR; Peterson GA; Hucek A J Behav Ther Exp Psychiatry; 1988 Jun; 19(2):119-26. PubMed ID: 3209696 [TBL] [Abstract][Full Text] [Related]
15. Group exposure for agoraphobics: a replication study. Teasdale JD; Walsh PA; Lancashire M; Mathews AM Br J Psychiatry; 1977 Feb; 130():186-93. PubMed ID: 837039 [TBL] [Abstract][Full Text] [Related]
16. Safety-signal therapy in agoraphobics: a preliminary test. Sartory G; Master D; Rachman S Behav Res Ther; 1989; 27(2):205-9. PubMed ID: 2930448 [TBL] [Abstract][Full Text] [Related]
17. Sequential combination of imipramine and self-directed exposure in the treatment of panic disorder with agoraphobia. Mavissakalian M J Clin Psychiatry; 1990 May; 51(5):184-8. PubMed ID: 2335493 [TBL] [Abstract][Full Text] [Related]
18. Failure to replicate evidence for phobic schemata in agoraphobic patients. Pickles AJ; van den Broek MD Br J Clin Psychol; 1988 Sep; 27(3):271-2. PubMed ID: 3191309 [TBL] [Abstract][Full Text] [Related]
19. How do desynchronous response systems relate to the treatment of agoraphobia: a follow-up evaluation. Craske MG; Sanderson WC; Barlow DH Behav Res Ther; 1987; 25(2):117-22. PubMed ID: 3593164 [No Abstract] [Full Text] [Related]
20. Temporal relationship between panic attack onset and phobic avoidance in agoraphobia. Thyer BA; Himle J Behav Res Ther; 1985; 23(5):607-8. PubMed ID: 4051933 [No Abstract] [Full Text] [Related] [Next] [New Search]